Symbiox Investme

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE653R01012
  • NSEID:
  • BSEID: 539278
INR
1.70
-0.09 (-5.03%)
BSENSE

Jun 18

BSE+NSE Vol: 3.5 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Symbiox Investme
Sungold Capital
Abhinav Leasing
Pasupati Fincap
Atharv Enter
K Z Leasing
Systematix Sec.
Voltaire Leasing
Superior Finleas
Munoth Commun.
SMC Credits
Why is Symbiox Investment & Trading Co Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0.85%
  • Poor long term growth as Operating profit has grown by an annual rate of -7.97%
2
Flat results in Mar 26
3
Stock is technically in a Mildly Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 21-May-26
  • Multiple factors for the stock are Bearish like RSI, MACD, Bollinger Band and KST
4
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.10% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -41.20% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Non Banking Financial Company (NBFC))

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Symbiox Investme for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Symbiox Investme
-46.2%
-0.56
73.99%
Sensex
-4.95%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-4.99%
EBIT Growth (5y)
2.11%
Net Debt to Equity (avg)
0
Institutional Holding
0
ROE (avg)
0.79%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
37
Industry P/E
21
Price to Book Value
0.18
EV to EBIT
-10.90
EV to EBITDA
-10.90
EV to Capital Employed
-0.71
EV to Sales
-6.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
0.47%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
PAT(Latest six months)

Higher at Rs 0.02 cr

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Symbiox Investme
Profit After Tax (PAT) - Latest six months
Higher at Rs 0.02 cr
than preceding 12 month period ended Mar 2026 of Rs -0.01 cr
MOJO Watch
In the half year the company has already crossed PAT of the previous twelve months

PAT (Rs Cr)